摘要
目的研究转化生长因子βⅡ型受体(TGF-βRⅡ)在胰腺癌组织中的表达情况,探讨其临床病理意义。方法应用免疫组化SP法结合微波抗原修复法检测50例胰腺癌和38例非胰癌组织(胰腺良性病变及正常组织)中TGF-βRⅡ表达情况。结果TGF-βRⅡ在胰腺癌组织中表达阳性率为96%(48/50),在非胰腺癌组织中表达阳性率为100%(38/38)。两者在统计学上差别无意义,但在表达的强度上存在差异。TGF-βRⅡ在胰腺癌组织中等强度以上表达率为70%(35/50),明显低于非胰腺癌组织100%(38/38)(P<0.01)。TGF-βRⅡ在胰腺癌中的表达强度随着组织分化程度的降低而降低(P<0.01)。结论TGF-βRⅡ低表达可能与胰腺癌的发生有关。TGF-βRⅡ的表达强度与胰腺癌的组织分化密切相关。
Objective\ To study the expression of the type Ⅱ transforming growth factorbeta receptor(TGFβRⅡ) in pancreatic carcinoma and its significance.\ Methods\ By using immunohistochemical methods,expression of TGFβRⅡ was studied in 50 cases of pancreatic carcinoma,38 cases of pancreatic nonneoplastic tissue(benign pancreatic diseases and normal pancreatic tissue).\ Results\ The positive rate of TGFβRⅡ in pancreatic carcinoma was 96%(48/50) and in pancreatic nonneoplastic tissue was 100%(38/38).\ But the rate of TGFβRⅡ expression with moderate intensity or more(~) in pancreatic carcinoma(70%,35/50) was lower than in pancreatic nonneoplastic tissue(100%,38/38)(P<0.01).\ The expression intensity of TGFβRⅡ in pancreatic carcinoma decreased with decreasing grades of differentiation (P<0.01).\ Conclusion\ Loss of TGFβRⅡ expression may be involved in pancreatic carcinoma.\ The expression intensity of TGFβRⅡ was closely correlated to differentiation of pancreatic carcinoma.
出处
《福建医科大学学报》
1998年第1期45-48,共4页
Journal of Fujian Medical University
关键词
胰腺肿瘤
转化生长因子Β
受体
免疫组织化学
type Ⅱ transforming growth factorbeta receptor\ \ pancreatic carcinomaimmunohistochemistry